Eukles Asset Management Novo Nordisk A S Transaction History

Eukles Asset Management

$244 Million
Q3 2024

A detailed history of Eukles Asset Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Eukles Asset Management holds 53,584 shares of NVO stock, worth $4.55 Million. This represents 2.61% of its overall portfolio holdings.

Number of Shares

53,584

Previous 53,955 0.69%

Holding current value

$4.55 Million

Previous $7.7 Million 17.15%

% of portfolio

2.61%

Previous 3.39%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$119.07 - $145.42 $44,174 - $53,950	-371 Reduced 0.69%	53,584 $6.38 Million
Q2 2024 Aug 01, 2024	SELL	$122.71 - $146.91 $46,384 - $55,531	-378 Reduced 0.7%	53,955 $7.7 Million
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $163,171 - $217,200	-1,598 Reduced 2.86%	54,333 $6.98 Million
Q4 2023 Jan 31, 2024	SELL	$87.78 - $105.45 $241,746 - $290,409	-2,754 Reduced 4.69%	55,931 $5.79 Million
Q3 2023 Oct 25, 2023	BUY	$90.94 - $199.54 $2.69 Million - $5.9 Million	29,550 Added 101.42%	58,685 $5.34 Million
Q2 2023 Aug 01, 2023	BUY	$155.98 - $172.65 $4,523 - $5,006	29 Added 0.1%	29,135 $4.71 Million
Q1 2023 Apr 28, 2023	SELL	$132.34 - $159.14 $35,731 - $42,967	-270 Reduced 0.92%	29,106 $4.63 Million
Q4 2022 Jan 27, 2023	BUY	$102.55 - $135.33 $20,920 - $27,607	204 Added 0.7%	29,376 $3.98 Million
Q3 2022 Oct 28, 2022	SELL	$95.28 - $116.93 $8,861 - $10,874	-93 Reduced 0.32%	29,172 $2.91 Million
Q2 2022 Jul 28, 2022	BUY	$103.24 - $121.81 $9,394 - $11,084	91 Added 0.31%	29,265 $3.26 Million
Q1 2022 Apr 27, 2022	SELL	$93.1 - $112.54 $30,629 - $37,025	-329 Reduced 1.12%	29,174 $3.24 Million
Q4 2021 Feb 10, 2022	BUY	$95.88 - $117.08 $53,692 - $65,564	560 Added 1.93%	29,503 $3.3 Million
Q3 2021 Oct 28, 2021	BUY	$84.42 - $106.62 $83,997 - $106,086	995 Added 3.56%	28,943 $2.78 Million
Q2 2021 Jul 27, 2021	BUY	$67.66 - $84.76 $134,846 - $168,926	1,993 Added 7.68%	27,948 $2.34 Million
Q1 2021 Apr 27, 2021	BUY	$67.06 - $75.82 $37,620 - $42,535	561 Added 2.21%	25,955 $1.75 Million
Q4 2020 Jan 26, 2021	BUY	$63.89 - $73.8 $38,461 - $44,427	602 Added 2.43%	25,394 $1.77 Million
Q3 2020 Oct 29, 2020	BUY	$63.69 - $70.22 $19,043 - $20,995	299 Added 1.22%	24,792 $1.72 Million
Q2 2020 Jul 29, 2020	BUY	$58.54 - $67.94 $84,707 - $98,309	1,447 Added 6.28%	24,493 $1.6 Million
Q1 2020 Apr 22, 2020	SELL	$49.46 - $64.78 $51,487 - $67,435	-1,041 Reduced 4.32%	23,046 $1.39 Million
Q4 2019 Jan 24, 2020	SELL	$49.86 - $58.26 $12,315 - $14,390	-247 Reduced 1.02%	24,087 $1.39 Million
Q3 2019 Oct 29, 2019	SELL	$47.54 - $53.43 $3,280 - $3,686	-69 Reduced 0.28%	24,334 $1.26 Million
Q2 2019 Aug 01, 2019	SELL	$46.79 - $52.47 $5,568 - $6,243	-119 Reduced 0.49%	24,403 $1.25 Million
Q1 2019 Apr 23, 2019	BUY	$46.36 - $52.63 $4,543 - $5,157	98 Added 0.4%	24,522 $1.28 Million
Q4 2018 Jan 22, 2019	BUY	$41.54 - $47.25 $1.01 Million - $1.15 Million	24,424 New	24,424 $1.13 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eukles Asset Management with notifications on news.

Account

Eukles Asset Management Novo Nordisk A S Transaction History